In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events ...

Innate lymphoid cells, which curiously behave like T cells even though they don’t recognize specific antigens, show promise as a potential cancer therapeutic.

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Modern unhealthy lifestyles and dietary habits have led to a yearly increase in the incidence of metabolism-related liver ...

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

CAR-T activity is still modest in GBM, and there are multiple limitations to its use in this setting, said Elena Garralda, MD ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

A novel machine learning model enhances colorectal cancer (CRC) prognosis and immunotherapy response prediction by ...